Skip to content

Zusanli acupoint injection for prevention and treatment of postoperative nausea and vomiting after painless gastroscopy

Zusanli acupoint injection for prevention and treatment of postoperative nausea and vomiting after painless gastroscopy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025001763
Enrollment
Unknown
Registered
2025-09-16
Start date
2025-09-17
Completion date
Unknown
Last updated
2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative nausea and vomiting

Interventions

Control group:Conventional treatment as control group
Intravenous injection group:Intravenous Injection
Acupuncture stimulation group:Acupuncture stimulation
Acupuncture point injection group:Zusanli acupoint injection

Sponsors

The Fourth Affiliated Hospital of China Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1: Female 2: 18 - 65 years old 3: American Society of Anesthesiologists (ASA) classification I-II 4: =2 Apfel risk factors (female nonsmoker history of PONV and/or motion sickness postoperative opioid use) 5: Expected operating time less than 1 hour 6: The subject or their legal guardian signs an informed consent form

Exclusion criteria

Exclusion criteria: 1: Pregnancy lactation or menstruation 2: The subject has severe gastrointestinal disease or gastroesophageal reflux disease 3: Complaints of nausea and/or vomiting 4: The subject has infection in the area of the acupoint injection or other factors affecting the injection 5: The subject has severe cardiac pulmonary renal or hepatic dysfunction central nervous system damage vertebral basilar artery insufficiency vestibular disease coagulation disorders or other types of blood disorders 6: Study drug allergies 7: Refuse to participate in the experiment 8: The subject uses of antiemetics opioids or glucocorticoids within 24 hours prior to surgery

Design outcomes

Primary

MeasureTime frame
Incidence of postoperative nausea and vomiting;

Secondary

MeasureTime frame
Incidence of postoperative nausea, vomiting, nausea and vomiting;Severity of postoperative nausea;Incidence of postoperative nausea, vomiting, nausea ;Grading of Nausea and Vomiting;

Countries

P.R.China

Contacts

Public ContactWang Yuanyuan

The Fourth Affiliated Hospital of China Medical University

wangyuanyuan@cmu.edu.cn18900912987

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026